Broadfin Capital
Latest statistics and disclosures from Broadfin Capital's latest quarterly 13F-HR filing:
- Top 5 stock holdings are TEVA, Alkermes, BABY, ANGO, SNTS. These five stock positions account for 36.92% of Broadfin Capital's total stock portfolio.
- Added to shares of TEVA (+$14.44M), BABY (+$11.22M), PGNX (+$10.88M), RIGL (+$8.45M), BDSI (+$8.05M), DSCI (+$6.94M), Cempra (+$5.91M), AUXL, DRRX, NUVA.
- Started new stock positions in SCMP, ONTY, PGNX, AUXL, MSON, NUVA, NKTR, BDSI, Cempra, Insmed, DRRX.
- Reduced shares in these stocks: SNTS (-$28.01M), MAKO, BMTI, Given Imaging, BSX, ABMD, NDZ, MAPP, MMSI, CPTS.
- Sold out of its positions in ATEC, BMTI, BSX, MAPP, NDZ, TSPT, Given Imaging.
- As of Dec. 31, 2012, Broadfin Capital has $404.17M in assets under management (AUM). Assets under management grew from a total value of $356.83M to $404.17M.
- Independent of market fluctuations, Broadfin Capital was a net buyer by $70.91M worth of stocks in the most recent quarter.
Broadfin Capital portfolio companies for quarter ending December 2012
| Ticker | Name | Portfolio Weight | Change | Share Count | Price | Last Trade |
|---|---|---|---|---|---|---|
| TEVA | Teva Pharmaceutical Industries | 10.63 | +50.00% | 1150621 | 37.34 | 39.48 |
| Alkermes | 7.61 | +3.00% | 1660954 | 18.52 | 0.00 | |
| BABY | Natus Medical | 7.43 | +59.00% | 2690992 | 11.16 | 14.28 |
| ANGO | AngioDynamics | 5.69 | +9.00% | 2092970 | 10.99 | 11.18 |
| SNTS | Santarus | 5.55 | -55.00% | 2044463 | 10.98 | 21.81 |
| HITK | Hi-Tech Pharmacal | 4.12 | 475864 | 34.98 | 33.73 | |
| Novadaq Technologies | 3.81 | +3.00% | 1745794 | 8.83 | 0.00 | |
| MMSI | Merit Medical Systems | 3.57 | -3.00% | 1037820 | 13.90 | 11.42 |
| ALR | Alere | 3.37 | +29.00% | 735625 | 18.50 | 25.27 |
| LCI | Lannett Company | 3.14 | +4.00% | 2560419 | 4.96 | 11.92 |
| IPXL | Impax Laboratories | 2.79 | +37.00% | 550873 | 20.49 | 18.75 |
| RIGL | Rigel Pharmaceuticals | 2.70 | +345.00% | 1676232 | 6.50 | 3.82 |
| PGNX | Progenics Pharmaceuticals | 2.69 | NEW | 3651666 | 2.98 | 4.90 |
| DEPO | DepoMed | 2.67 | +35.00% | 1745575 | 6.19 | 6.05 |
| STJ | St. Jude Medical | 2.38 | +51.00% | 265703 | 36.14 | 45.96 |
| SLTM | Solta Medical | 2.29 | 3471036 | 2.67 | 2.21 | |
| EBS | Emergent BioSolutions | 2.27 | +14.00% | 572400 | 16.04 | 14.73 |
| DSCI | Derma Sciences | 2.13 | +416.00% | 775000 | 11.11 | 13.49 |
| BDSI | BioDelivery Sciences International | 1.99 | NEW | 1867000 | 4.31 | 4.68 |
| FLML | Flamel Technologies S.A. | 1.87 | +91.00% | 2491261 | 3.03 | 6.16 |
| Anacor Pharmaceuticals In | 1.81 | +44.00% | 1404959 | 5.20 | 0.00 | |
| MAKO | MAKO Surgical | 1.59 | -37.00% | 500000 | 12.85 | 12.51 |
| Qlt | 1.53 | 784893 | 7.86 | 0.00 | ||
| Cempra | 1.46 | NEW | 923077 | 6.40 | 0.00 | |
| TSRX | Trius Therapeutics | 1.43 | +14.00% | 1211788 | 4.78 | 8.57 |
| ABMD | ABIOMED | 1.33 | -19.00% | 400000 | 13.44 | 21.92 |
| MASI | Masimo Corporation | 1.30 | +78.00% | 250837 | 21.01 | 22.37 |
| AUXL | Auxilium Pharmaceuticals | 1.15 | NEW | 250000 | 18.54 | 17.19 |
| ATRC | AtriCure | 1.13 | 660441 | 6.90 | 9.11 | |
| DRRX | DURECT Corporation | 1.11 | NEW | 4870000 | 0.92 | 0.84 |
| ARTC | ArthroCare Corporation | 1.09 | +15.00% | 127206 | 34.59 | 36.20 |
| Intellipharmaceuticsintl Inc C | 1.07 | 1728221 | 2.50 | 0.00 | ||
| NUVA | NuVasive | 1.05 | NEW | 274876 | 15.46 | 22.72 |
| NXTM | NxStage Medical | 0.93 | +21.00% | 335100 | 11.25 | 14.37 |
| NKTR | Nektar Therapeutics | 0.92 | NEW | 500000 | 7.41 | 10.74 |
| RMTI | Rockwell Medical Technologies | 0.62 | 312566 | 8.05 | 4.06 | |
| Insmed | 0.44 | NEW | 267240 | 6.69 | 0.00 | |
| CPTS | Conceptus | 0.40 | -21.00% | 77360 | 21.01 | 0.00 |
| ONTY | Oncothyreon | 0.36 | NEW | 750000 | 1.92 | 1.80 |
| BEAT | Cardionet | 0.18 | +16.00% | 323498 | 2.28 | 6.07 |
| CASM | CAS Medical Systems | 0.12 | -4.00% | 221494 | 2.15 | 1.70 |
| Zeltiq Aesthetics | 0.12 | 101450 | 4.63 | 0.00 | ||
| MSON | Misonix | 0.08 | NEW | 42604 | 8.05 | 5.29 |
| SCMP | Sucampo Pharmaceuticals | 0.07 | NEW | 57912 | 4.90 | 6.92 |
Past 13F-HR SEC Filings for Broadfin Capital
- Broadfin Capital 2012 Q3 - filed Nov. 14, 2012
- Broadfin Capital 2012 Q1 - filed May 15, 2012
- Broadfin Capital 2011 Q4 - filed Feb. 13, 2012
- Broadfin Capital 2011 Q3 - filed Nov. 14, 2011
- Broadfin Capital 2011 Q2 - filed Aug. 15, 2011
- Broadfin Capital 2011 Q1 - filed May 16, 2011
- Broadfin Capital 2010 Q4 - filed Feb. 14, 2011